Clopidogrel plus long-term aspirin after femoro-popliteal stenting. The CLAFS project: 1- and 2-year results

European Radiology

Volumn 14, Issue 2, 2004, Pages 302-308

  Strecker, Ernst Peter K ^a   Boos, Irene B L ^a   Göttmann, Dieter ^a   Vetter, Sylvia ^a  

^a Diakonissen Hospital   (Germany)

Author keywords

Antiplatelet therapy; Arteries; Extremities; Obstruction; Stenosis; Stents; Transluminal angioplasty

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 10A INHIBITOR; CLOPIDOGREL; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; REVIPARIN; TANTALUM; WARFARIN;

ANEURYSM; ANTICOAGULATION; ARTERIOGRAPHY; ARTICLE; BLEEDING; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER FLOWMETRY; DOSE RESPONSE; DRUG COST; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; ECHOGRAPHY; FEMORAL ARTERY; FEMOROPOPLITEAL BYPASS; FIBRINOLYSIS; FOLLOW UP; HEMATOMA; HUMAN; INTERVENTIONAL RADIOLOGY; LONG TERM CARE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPLITEAL ARTERY; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESTENOSIS; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; STENT; VASCULAR PATENCY;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANGIOGRAPHY; ANGIOPLASTY, BALLOON; ANTICOAGULANTS; ARTERIAL OCCLUSIVE DISEASES; ASPIRIN; BLOOD FLOW VELOCITY; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FEMORAL ARTERY; FIBRINOLYSIS; FOLLOW-UP STUDIES; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; LONG-TERM CARE; MALE; MIDDLE AGED; POPLITEAL ARTERY; PROSTHESIS FAILURE; RECURRENCE; RETROSPECTIVE STUDIES; STENTS; TANTALUM; TICLOPIDINE; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, COLOR; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 0842280664     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-003-2003-8     Document Type: Article

References (26)

1. Henry M, Amor M, Ethevenot G et al. (1995) Palmaz stent placement in iliac and femoropopliteal arteries: primary and secondary patency in 310 patients with 2-4 year follow-up. Radiology 196:167-174
2. Martin EC, Katzen BT, Benenati JF et al. (1995) Multicenter trial of the wall-stent in the iliac and femoral arteries. J Vasc Interv Radiol 6:843-849
3. Strecker EP, Boos IBL, Göttmann D (1997) Femoropopliteal artery stent placement: evaluation of long-term success. Radiology 205:375-383
4. Cejna M, Schoder M, Lammer J (1999) PTA vs stent in femoro-popliteal obstruction. Radiologe 39:144-150
5. Müller-Hülsbeck S, Schwarzenberg H, Steffens JC, Kopp U et al. (1998) RöFo 168:604-609
6. Roubin GS, Cannon AD, Agrawal SK et al. (1992) Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation 85:916-927
7. George BS, Voorhees WD, Roubin GS et al. (1993) Multicenter investigation of coronary stenting to treat acute or threatened closure complicating percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 22:135-143
8. Topol EJ (1994) Caveats about elective coronary stenting. N Engl J Med 331:539-541
9. Strecker EPK, Goettmann D, Boos IBL, Vetter S (1998) Low-molecular-weight heparin (reviparin) reduces the incidence of femoropopliteal instent-stenosis: preliminary results of an ongoing study. Cardiovasc Intervent Radiol 21:375-379
10. Bertrand ME, Rupprecht HJ, Urban P et al. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting. The Clopidogrel Aspirin Stent International Cooperative Study (CLASSICS)
11. Bhatt DL, Kapadia SR, Bajzer CT, Chew DP et al. (2001) J Invasive Cardiol 13:767-771
12. Bhatt DL, Bertrand ME, Berger PB, L'Allier PL et al. (2002) J Am Coll Cardiol 39:9-14
13. Jahnke T, Voshage G, Müller-Hülsbeck S, Grimm J et al. (2002) J Vasc Intervent Radiol 13:257-266
14. Wolfram RM, Pokrajac B, Ahmadi R, Maca T et al. (2001) Endovascular brachytherapy for the prophylaxis of restenosis after long-segment femoral stenting: mid-term results of a pilot study. Cardiovasc Interv Radiol 220:724-729
15. Rutherford RB, Becker GJ (1991) Standards for evaluating and reporting the results of surgical and percutaneous therapy for peripheral artery disease. J Vasc Intervent Radiol 2:169-174
16. Kresowik J, Khozry MD, Miller BV et al. (1991) A prospective study of the incidence and natural history of femoral vascular complications after percutaneous transluminal coronary angioplasty. Vasc Surg 13:328-333
17. Gray, Olin (1997) Limitations of percutaneous transluminal angioplasty with stenting for femoropopliteal artery occlusive disease. Semin Vasc Surg 10:8-16
18. Jung EM, Lutz R, Clevert DA, Rupp N (2001) B-Flow: sonographic assessment and therapy for femoral artery pseudoaneurysm. RoFo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 173:805-809
19. Chatelard P, Guibourt C (1996) Long-term results with a Palmaz stent in the femoropopliteal arteries. J Cardiovasc Surg Torino 37 (Suppl 1):67-72
20. Richter GM, Simon C, Dahlke A et al. (1997) Long-term results of the randomized European trial femoral stent vs angioplasty (REFSA) study. Cardiovasc Intervent Radiol 20 (Suppl 1):S73
21. Sapoval MR, Long AL, Raynaud AC et al. (1992) Femoropopliteal stent placement: long-term results. Radiology 184:833-839
22. Starck E, Knaupp D, Dukiet D et al. (1996) Memotherm and tantalum stents in femoropopliteal arteries (abstract). Fifth International and Interdisciplinary Symposium on Endoluminal Stems and Grafts, 10-13 October. Georgetown University Medical Center, Washington D.C.
23. Strecker EP, Boos I, Goettmann D, ≤Vetter S (2001) Fourteen years of experience with iliac and femoral stent implantation with regard to post-procedural medication. Cardiovasc Intervent Radiol 24 (Suppl 1): S153
24. Claeys MJ, van der Planken MG, Michiels JJ, Vertessen F et al. (2002) Comparison of antiplatelet effect of loading dose of clopidogrel vs abciximab during coronary intervention. Blood Coagul Fibrinol 13:283-288
25. Islam MA, Blankenship JC, Balog C, Iliadis EA et al. (2002) Effect of abciximab on angiographic complications during percutaneous coronary stenting in the evaluation of platelet IIb/IIIa inhibition in stenting trial (EPISTENT). Am J Cardiol 90:916-921
26. Topol EJ, Lincoff AM, Kereiakes DJ, Kleiman NS et al. (2002) Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularization. Am J Med 113:1-6